Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Meriem Ighilahriz"'
Autor:
Meriem Ighilahriz, Sergey Nikolaev, Andrey A. Yurchenko, Maxime Battistella, Samia Mourah, Fanélie Jouenne, Emanuelle Bourrat, Nicole Basset-Seguin
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 4, p adv00434 (2021)
Externí odkaz:
https://doaj.org/article/898844f7ec4a457daa145eae3d1c6505
Autor:
Andrey A. Yurchenko, Oltin T. Pop, Meriem Ighilahriz, Ismael Padioleau, Fatemeh Rajabi, Hayley J. Sharpe, Nicolas Poulalhon, Brigitte Dreno, Amir Khammari, Marc Delord, Antonio Alberti, Nadem Soufir, Maxime Battistella, Samia Mourah, Fanny Bouquet, Ariel Savina, Andrej Besse, Max Mendez-Lopez, Florent Grange, Sandrine Monestier, Laurent Mortier, Nicolas Meyer, Caroline Dutriaux, Caroline Robert, Philippe Saiag, Florian Herms, Jerome Lambert, Frederic J. de Sauvage, Nicolas Dumaz, Lukas Flatz, Nicole Basset-Seguin, Sergey I. Nikolaev
Publikováno v:
Clinical Cancer Research
Clinical Cancer Research, 2022, pp.clincanres.3764.2021. ⟨10.1158/1078-0432.CCR-21-3764⟩
Clinical Cancer Research, 2022, pp.clincanres.3764.2021. ⟨10.1158/1078-0432.CCR-21-3764⟩
Purpose: Vismodegib is approved for the treatment of locally advanced basal cell carcinoma (laBCC), but some cases demonstrate intrinsic resistance (IR) to the drug. We sought to assess the frequency of IR to vismodegib in laBCC and its underlying ge
Autor:
Sergey I. Nikolaev, Nicole Basset-Seguin, Lukas Flatz, Nicolas Dumaz, Frederic J. de Sauvage, Jerome Lambert, Florian Herms, Philippe Saiag, Caroline Robert, Caroline Dutriaux, Nicolas Meyer, Laurent Mortier, Sandrine Monestier, Florent Grange, Max Mendez-Lopez, Andrej Besse, Ariel Savina, Fanny Bouquet, Samia Mourah, Maxime Battistella, Nadem Soufir, Antonio Alberti, Marc Delord, Amir Khammari, Brigitte Dreno, Nicolas Poulalhon, Hayley J. Sharpe, Fatemeh Rajabi, Ismael Padioleau, Meriem Ighilahriz, Oltin T. Pop, Andrey A. Yurchenko
Supplementary Figure from Frequency and Genomic Aspects of Intrinsic Resistance to Vismodegib in Locally Advanced Basal Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::351f6102c14b7c4e17ca3b39ea656edf
https://doi.org/10.1158/1078-0432.22487462.v1
https://doi.org/10.1158/1078-0432.22487462.v1
Autor:
Sergey I. Nikolaev, Nicole Basset-Seguin, Lukas Flatz, Nicolas Dumaz, Frederic J. de Sauvage, Jerome Lambert, Florian Herms, Philippe Saiag, Caroline Robert, Caroline Dutriaux, Nicolas Meyer, Laurent Mortier, Sandrine Monestier, Florent Grange, Max Mendez-Lopez, Andrej Besse, Ariel Savina, Fanny Bouquet, Samia Mourah, Maxime Battistella, Nadem Soufir, Antonio Alberti, Marc Delord, Amir Khammari, Brigitte Dreno, Nicolas Poulalhon, Hayley J. Sharpe, Fatemeh Rajabi, Ismael Padioleau, Meriem Ighilahriz, Oltin T. Pop, Andrey A. Yurchenko
Purpose:Vismodegib is approved for the treatment of locally advanced basal cell carcinoma (laBCC), but some cases demonstrate intrinsic resistance (IR) to the drug. We sought to assess the frequency of IR to vismodegib in laBCC and its underlying gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a2b97d45e46bb583500481210757562
https://doi.org/10.1158/1078-0432.c.6532523.v1
https://doi.org/10.1158/1078-0432.c.6532523.v1
Autor:
Emanuelle Bourrat, Nicole Basset-Seguin, Samia Mourah, Fanélie Jouenne, Andrey A. Yurchenko, Meriem Ighilahriz, Maxime Battistella, Sergey Nikolaev
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 4, p adv00434 (2021)
Autor:
S. Mourah, S. Nikolaev, Nicole Basset-Seguin, Fanny Bouquet, Meriem Ighilahriz, M. Benfodda, Hayley J. Sharpe, Nicolas Dumaz, Marisa Battistella, Nadem Soufir, Ariel Savina
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 33
Autor:
Sergey Nikolaev, Nicolas Dumaz, A. Alberti, M. Delord, Nicole Basset-Seguin, Andrey A. Yurchenko, O. Tiberiu Pop, Hayley J. Sharpe, Meriem Ighilahriz, F. de Sauvage
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 147:A15
Les inhibiteurs de la voie Hedgehog (5Hh) ont transforme le devenir des patients atteints de CBC avances (CBCla). La majorite des patients sont repondeurs, mais une faible proportion sont resistants primaires (RP) et les mecanismes de cette resistanc
Autor:
Ariel Savina, Maxime Battistella, M. Benfodda, Nadem Soufir, Fanny Bouquet, Nicole Basset Seguin, Samia Mourah, Nicolas Dumaz, Meriem Ighilahriz
Publikováno v:
Journal of Clinical Oncology. 36:e21559-e21559
e21559Background: Vismodegib , a selective Hh pathway inhibitor that targets Smoothened (SMO) is a major therapeutic breakthrough for locally advanced (la) or metastatic BCC. During treatment some ...